Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership200,953 shares
Latest Disclosed Value $ 7,660,328
Jpmorgan Chase & Co ownership in HTD / Corcept Therapeutics Incorporated

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 200,953 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $6,930,869 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 834,449 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -75.92% during the quarter. The current value of the position is $12,708,268 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (HTD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HTD / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 200,953 -633,496 -75.92 7,660 -73.62 0.0001
2026-05-13 2026-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 0 -100.00 0
2026-02-11 2025-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 834,449 -15,415 -1.81 29,039 -58.89 0.0018
2025-11-26 2025-09-30 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 849,864 587,053 223.37 70,632 266.16 0.0042
2025-11-07 2025-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 849,864 587,053 70,632 0.0004
2025-08-12 2025-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 262,811 -27,964 -9.62 19,290 -41.92 0.0013
2025-05-12 2025-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 290,775 30,873 11.88 33,212 153.60 0.0024
2025-02-12 2024-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 259,902 6,832 2.70 13,096 11.82 0.0010
2024-12-26 2024-09-30 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 253,070 76,573 43.38 11,712 104.26 0.0009
2024-11-08 2024-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 253,070 76,573 11,712 0.0009
2024-12-26 2024-06-30 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 176,497 -17,074 -8.82 5,734 17.60 0.0005
2024-08-12 2024-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 176,497 -17,074 5,734 0.0005
2024-12-26 2024-03-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 193,571 -6,013 -3.01 4,876 -24.78 0.0004
2024-05-10 2024-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 193,571 -6,013 4,876 0.0004
2024-12-26 2023-12-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 199,584 7,000 3.63 6,482 23.56 0.0006
2024-02-12 2023-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 199,584 7,000 6,482 0.0006
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 192,584 -29,922 -13.45 5,247 5.98 0.0006
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 222,506 -68,086 -23.43 4,951 -21.35 0.0005
2023-05-18 2023-03-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 290,592 48,146 19.86 6,294 157,250.00 0.0008
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 177,487 -64,959 4,861 0.0001
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 242,446 10,435 4.50 5 -99.93 0.0006
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 232,011 3,296 1.44 5,950 9.40 0.0009
2022-08-11 2022-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 228,715 12,634 5.85 5,439 11.78 0.0008
2022-05-11 2022-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 216,081 5,036 2.39 4,866 16.44 0.0006
2022-02-11 2021-12-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 211,045 -313,577 -59.77 4,179 -59.53 0.0005
2022-02-10 2021-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 211,045 -313,577 4,179 0.0005
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 524,622 -135,161 -20.49 10,325 -28.87 0.0013
2021-08-12 2021-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 659,783 469,589 246.90 14,515 220.77 0.0017
2021-05-12 2021-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 190,194 -9,051 -4.54 4,525 -13.18 0.0006
2021-02-19 2020-12-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 199,245 92,892 87.34 5,212 179.16 0.0008
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 199,245 92,892 5,212 128.8965
2020-11-12 2020-09-30 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 106,353 43,277 68.61 1,867 75.80 0.0003
2020-11-12 2020-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 106,353 1,867
2020-08-11 2020-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 63,076 22,544 55.62 1,062 119.88 0.0002
2020-05-12 2020-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 40,532 -171 -0.42 483 -1.83 0.0001
2020-02-11 2019-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 40,703 3,689 9.97 492 -6.11 0.0001
2019-11-12 2019-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 37,014 3,373 10.03 524 39.73 0.0001
2019-08-07 2019-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 33,641 -122,033 -78.39 375 -79.47 0.0001
2019-05-07 2019-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 155,674 126,204 428.25 1,827 363.71 0.0004
2019-02-11 2018-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 29,470 -81,939 -73.55 394 -74.76 0.0001
2018-11-13 2018-09-30 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 111,409 44,169 65.69 1,561 47.54 0.0003
2018-11-07 2018-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 111,409 44,169 1,561
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 67,240 -160,518 -70.48 1,058 -71.76 0.0002
2018-05-10 2018-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 227,758 51,576 29.27 3,747 17.76 0.0008
2018-02-13 2017-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 176,182 172,046 4,159.72 3,182 3,927.85 0.0007
2017-11-09 2017-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 4,136 1,947 88.94 79 203.85 0.0000
2017-08-09 2017-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 2,189 -9,758 -81.68 26 -80.15 0.0000
2017-05-10 2017-03-31 13F CORCEPT THERAPEUTICS COMMON 218352102 11,947 -57,888 -82.89 131 -74.16 0.0000
2017-02-06 2016-12-31 13F CORCEPT THERAPEUTICS COMMON 218352102 69,835 69,835 143.06 507 1,002.17 0.0001
2014-02-26 2013-12-31 13F/A-1 CORCEPT THERAPEUTICS COMMON 218352102 0 -28,732 -100.00 0 -100.00
2013-10-31 2013-09-30 13F CORCEPT THERAPEUTICS COMMON 218352102 28,732 -651 -2.22 46 -9.80 0.0000
2013-08-13 2013-06-30 13F CORCEPT THERAPEUTICS COMMON 218352102 29,383 29,383 51 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-13 2018-09-30 13F/A CORCEPT THERAPEUTICS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS OPTION Call 100,000 1,572 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-11-13 2018-09-30 13F/A CORCEPT THERAPEUTICS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS OPTION Put 168,500 2,649 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.